The biosimilars market—offering cost-effective, near-biologic therapies—is set for rapid expansion. India’s growing role complements major global momentum, driven by patent expirations, chronic disease prevalence, and supportive regulatory frameworks worldwide.
Biosimilars-market
Request a sample copy of research...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek